EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 306 filers reported holding EDITAS MEDICINE INC in Q4 2021. The put-call ratio across all filers is 3.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $186,328 | -69.7% | 39,899 | -51.8% | 0.00% | -100.0% |
Q1 2024 | $614,450 | -71.8% | 82,810 | -61.5% | 0.00% | -50.0% |
Q4 2023 | $2,178,061 | -58.3% | 215,011 | -60.9% | 0.00% | -71.4% |
Q3 2023 | $5,218,746 | +25.8% | 550,270 | +61.4% | 0.01% | +40.0% |
Q2 2023 | $4,147,607 | -5.6% | 341,008 | -23.1% | 0.01% | -16.7% |
Q1 2023 | $4,395,175 | -0.5% | 443,277 | +66.3% | 0.01% | -14.3% |
Q4 2022 | $4,417,650 | -99.9% | 266,582 | +38.3% | 0.01% | -36.4% |
Q3 2022 | $6,562,904,000 | +17.2% | 192,754 | +105.4% | 0.01% | +22.2% |
Q2 2022 | $5,598,098,000 | -42.7% | 93,844 | -39.0% | 0.01% | -30.8% |
Q1 2022 | $9,766,884,000 | +102.9% | 153,938 | +21.3% | 0.01% | +85.7% |
Q4 2021 | $4,814,550,000 | +9.9% | 126,889 | +19.0% | 0.01% | +16.7% |
Q3 2021 | $4,381,182,000 | +184.7% | 106,650 | +292.5% | 0.01% | +200.0% |
Q2 2021 | $1,539,022,000 | -17.1% | 27,172 | -38.5% | 0.00% | -33.3% |
Q1 2021 | $1,856,904,000 | -14.9% | 44,212 | +42.1% | 0.00% | -25.0% |
Q4 2020 | $2,181,753,000 | +277.0% | 31,119 | +50.9% | 0.00% | +300.0% |
Q3 2020 | $578,709,000 | +17.2% | 20,624 | +23.5% | 0.00% | 0.0% |
Q2 2020 | $493,897,000 | -42.1% | 16,697 | -61.2% | 0.00% | -50.0% |
Q1 2020 | $853,285,000 | -83.5% | 43,030 | -75.4% | 0.00% | -77.8% |
Q4 2019 | $5,185,303,000 | +2570.7% | 175,120 | +1951.1% | 0.01% | – |
Q3 2019 | $194,154,000 | +26.7% | 8,538 | +37.9% | 0.00% | – |
Q2 2019 | $153,190,000 | -40.8% | 6,192 | -41.5% | 0.00% | -100.0% |
Q1 2019 | $258,852,000 | +1059.8% | 10,587 | +979.2% | 0.00% | – |
Q4 2018 | $22,318,000 | -71.8% | 981 | -60.6% | 0.00% | – |
Q3 2018 | $79,232,000 | -3.1% | 2,490 | +9.1% | 0.00% | – |
Q2 2018 | $81,800,000 | -68.0% | 2,283 | -70.4% | 0.00% | – |
Q1 2018 | $255,586,000 | +14.2% | 7,710 | +5.9% | 0.00% | – |
Q4 2017 | $223,776,000 | +144.5% | 7,282 | +91.0% | 0.00% | – |
Q3 2017 | $91,526,000 | +38.1% | 3,812 | -3.5% | 0.00% | – |
Q2 2017 | $66,264,000 | +573.2% | 3,949 | +795.5% | 0.00% | – |
Q1 2017 | $9,843,000 | -4.3% | 441 | -30.4% | 0.00% | – |
Q4 2016 | $10,290,000 | +4.0% | 634 | -13.6% | 0.00% | – |
Q3 2016 | $9,894,000 | +48.5% | 734 | +168.9% | 0.00% | – |
Q2 2016 | $6,661,000 | – | 273 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deep Track Capital, LP | 6,000,000 | $28,020,000 | 0.84% |
Knott David M Jr | 177,000 | $827 | 0.33% |
Integral Health Asset Management, LLC | 675,000 | $3,152,250 | 0.30% |
Avidity Partners Management LP | 816,000 | $3,810,720 | 0.16% |
Green Alpha Advisors, LLC | 30,267 | $141,347 | 0.11% |
PDT Partners, LLC | 246,537 | $1,151,328 | 0.11% |
Spectrum Planning & Advisory Services Inc. | 12,051 | $57,122 | 0.06% |
Woodline Partners LP | 970,491 | $4,532,193 | 0.04% |
Hennion & Walsh Asset Management, Inc. | 168,371 | $786,293 | 0.04% |
Virtus ETF Advisers LLC | 16,489 | $77,004 | 0.04% |